SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) – February 15, 2006
________________________
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
_____________________
|
|
|
|
|
Pennsylvania |
1-8036 |
23-1210010 |
|
(State or other jurisdiction |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
|
|
101 Gordon Drive, PO Box 645, Lionville, PA |
|
19341-0645 |
|
(Address of principal executive offices) |
|
(Zip Code) |
(610) 594-2900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 9.01 Financial Statements and Exhibits
|
(b) |
Pro Forma Financial Information |
Attached hereto as Exhibit 99.1 is unaudited pro forma condensed consolidated financial information for West Pharmaceutical Services, Inc. and subsidiaries for the year ended December 31, 2004 and the nine months ended September 30, 2005. Such information is being filed for purposes of incorporation by reference into the Company’s Registration Statement on Form S-3 (Registration No. 333-128438) filed under the Securities Act of 1933, as amended.
|
(c) |
Exhibits |
|
99.1 |
Unaudited pro forma condensed consolidated financial information. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
WEST PHARMACEUTICAL SERVICES, INC. |
|
|
|
/s/ William J. Federici |
|
William J. Federici |
|
Vice President and Chief Financial Officer |
February 15, 2006
EXHIBIT INDEX
Description
99.1 Unaudited pro forma condensed consolidated financial information.